Tobacco smoking, epilepsy, and seizures

Epilepsy and Behavior

Volumn 31, Issue , 2014, Pages 210-218

  Rong, Lingling ^a   Frontera Jr , Alfred T ^a   Benbadis, Selim R ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Epilepsy; Nicotine; Nicotinic acetylcholine receptor (nAChR); Seizure; Smoking cessation agent; Tobacco smoking

Indexed keywords

ELECTRONIC CIGARETTE; NICOTINE; TOBACCO SMOKE;

ANTICONVULSANT ACTIVITY; BABY; DEATH; DISEASE ASSOCIATION; EPILEPSY; HUMAN; MATERNAL SMOKING; MEDICAL LITERATURE; NONHUMAN; PASSIVE SMOKING; PREGNANCY; REVIEW; RISK ASSESSMENT; SEIZURE; SMOKING; SMOKING CESSATION;

EPILEPSY; NICOTINE; NICOTINIC ACETYLCHOLINE RECEPTOR (NACHR); SEIZURE; SMOKING CESSATION AGENT; TOBACCO SMOKING;

ANIMALS; EPILEPSY; FEMALE; HUMANS; MALE; NICOTINE; PREGNANCY; RISK FACTORS; SMOKING;

EID: 84892495442     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2013.11.022     Document Type: Review

References (131)

1. World Health Organization report on the global tobacco epidemic Warning about the dangers of tobacco 2011, 8. [http://whqlibdoc.who.int/publications/2011/9789240687813_eng.pdf].
2. Gustavsson P., Jansson C., Hogstedt C. Incidence of myocardial infarction in Swedish chimney sweeps 1991-2005: a prospective cohort study. Occup Environ Med 2013, 70(7):505-507.
3. Jansson C., Alderling M., Hogstedt C., Gustavsson P. Mortality among Swedish chimney sweeps (1952-2006): an extended cohort study. Occup Environ Med 2012, 69(1):41-47.
4. Vander Weg M.W., Rosenthal G.E., Vaughan Sarrazin M. Smoking bans linked to lower hospitalizations for heart attacks and lung disease among Medicare beneficiaries. Health Aff (Millwood) 2012, 31(12):2699-2707.
5. He Y., Jiang B., Li L.S., Ko L., Wu L., Sun D.L., et al. Secondhand smoke exposure predicted COPD and other tobacco related mortality in a 17year cohort study in China. Chest 2012, 142(4):909-918.
6. Du Plooy J.N., Buys A., Duim W., Pretorius E. Comparison of platelet ultrastructure and elastic properties in thrombo-embolic ischemic stroke and smoking using atomic force and scanning electron microscopy. PLoS One 2013, 8(7):e69774. 10.1371/journal.pone.0069774.
7. Miyake Y., Tanaka K., Arakawa M. Active and passive maternal smoking during pregnancy and birth outcomes: the Kyushu Okinawa Maternal and Child Health Study. BMC Pregnancy Childbirth 2013, 13(1):157.
8. Talhout R., Schulz T., Florek E., Benthem J.V., Wester P., Opperhuizen A. Hazardous compounds in tobacco smoke. Int J Environ Res Public Health 2011, 8(2):613-628.
9. (Page Last Updated: 07/09/2013). http://www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/ucm297786.htm.
10. (Page Last Updated: 07/09/2013). http://www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/ucm297752.htm.
11. Woolf A., Burkhart K., Caraccio T., Litovitz T. Self-poisoning among adults using multiple transdermal nicotine patches. J Toxicol Clin Toxicol 1996, 34(6):691-698.
12. Kurt F., Bektas O., Kalkan G., Oncel M.Y., Yakut H.I., Kocabas C.N. Does age affect presenting symptoms in children with carbon monoxide poisoningα. Pediatr Emerg Care 2013, 29(8):916-921.
13. Brown K.L., Wilson R.F., White M.T. Carbon monoxide induced status epilepticus in an adult. J Burn Care Res 2007, 28(3):533-536.
14. Durnin C. Carbon monoxide poisoning presenting with focal epileptiform seizures. Lancet 1987, 1(8545):1319-1320.
15. Mori T., Nagai K. Carbon-monoxide poisoning presenting as an afebrile seizure. Pediatr Neurol 2000, 22(4):330-331.
16. Herman L. Carbon monoxide poisoning presenting as an isolated seizure. J Emerg Med 1998, 16(3):429-432.
17. Shin W.K., Jang Y.E., Lee H., Min S.H., Ryu H.G. Sudden severe hyperammonemia and status epilepticus-a case report. Korean J Anesthesiol 2013, 65(3):262-265.
18. Sakai Y., Abo W., Yagita K., Tanaka T., Doi T., Fuke C. Chemical burn with systemic cresol intoxication. Pediatr Int 1999, 41(2):174-176.
19. Ortel T.L., Bedrosian C.L., Simel D.L. Arsenic poisoning and seizures. N C Med J 1987, 48(12):627-630.
20. Confer A.W., Ward B.C., Hines F.A. Arsanilic acid toxicity in rabbits. Lab Anim Sci 1980, 30(2 Pt 1):234-236.
21. Mesdaghinia A., Yazdanpanah H., Seddighi M., Banafshe H.R., Heydari A. Effect of short term lead exposure on PTZ-induced seizure threshold in mice. Toxicol Lett 2010, 199(1):6-9.
22. Chan M.H., Chen H.H. Toluene exposure increases aminophylline-induced seizure susceptibility in mice. Toxicol Appl Pharmacol 2003, 193(2):303-308.
23. Silva-Filho A.R., Pires M.L., Shiotsuki N. Anticonvulsant and convulsant effects of organic solvents. Pharmacol Biochem Behav 1992, 41(1):79-82.
24. Seven M., Basaran S.Y., Cengiz M., Unal S., Yuksel A. Deficiency of selenium and zinc as a causative factor for idiopathic intractable epilepsy. Epilepsy Res 2013, 104(1-2):35-39.
25. 2 is a potent, fast acting inhalation anticonvulsant. Epilepsia 2011, 52(1):104-114.
26. Cruz S.L., Gauthereau M.Y., Camacho-Munoz C., Lopez-Rubalcava C., Balster R.L. Effects of inhaled toluene and 1,1,1-trichloroethane on seizures and death produced by N-methyl-D-aspartic acid in mice. Behav Brain Res 2003, 140(1-2):195-202.
27. Likhodii S., Nylen K., Burnham W.M. Acetone as an anticonvulsant. Epilepsia 2008, 49(Suppl. 8):83-86.
28. Rehni A.K., Singh N. Reversal of pentylenetetrazole-induced seizure activity in mice by nickel chloride. Indian J Pharmacol 2009, 41(1):15-18.
29. Scheffer I.E., Bhatia K.P., Lopes-Cendes I., Fish D.R., Marsden C.D., Andermann E., et al. Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder. Lancet 1994, 343(8896):515-517.
30. Steinlein O.K., Kaneko S., Hirose S. Nicotinic acetylcholine receptor mutations. Jasper's basic mechanisms of the epilepsies 2012, 1-15. National center for Biotechnology Information (US), Bethesda (MD). 4th ed. J.L. Noebels, M. Avoli, M.A. Rogawski, R.W. Olsen, A.V. Delgado-Escueta (Eds.).
31. Willoughby J.O., Pope K.J., Eaton V. Nicotine as an antiepileptic agent in ADNLEF: an N-of-one study. Epilepsia 2003, 44(9):1238-1240.
32. Zerem A., Nishri D., Yosef Y., Blumkin L., Lev D., Leshinsky-Silver E., et al. Resolution of epileptic encephalopathy following treatment with transdermal nicotine. Epilepsia 2013, 54(1):e13-e15.
33. Parikh M.S., Haltiner A.M., de Menezes M.S., Caylor L.M., Sepkuty J.P., Simon E.A., et al. Nicotine patches-do they influence seizure number, stay durations or seizure rate during video EEG telemetryα. Epilepsy Behav 2012, 23(3):389-391.
34. Brodtkorb E., Picard F. Tobacco habits modulate autosomal dominant nocturnal frontal lobe epilepsy. Epilepsy Behav 2006, 9(3):515-520.
35. Naldi I., Bisulli F., Vignatelli L., Licchetta L., Pittau F., Di Vito L., et al. Tobacco habits in nocturnal frontal lobe epilepsy. Epilepsy Behav 2013, 26(1):114-117.
36. Dworetzky B.A., Bromfield E.B., Townsend M.K., Kang J.H. A prospective study of smoking, caffeine, and alcohol as risk factors for seizures or epilepsy in young adult women: data from the nurses' health study II. Epilepsia 2010, 51(2):198-205.
37. de Carvalho J.F., Pasoto S.G., Appenzeller S. Seizures in primary antiphospholipid syndrome: the relevance of smoking to stroke. Clin Dev Immunol 2012, 2012:981519. 10.1155/2012/981519.
38. Li X., Zhao Z., Liu G., Jin X.X., Chen Y., Hu D.Y. Survey of influencing factors on smoking and cessation compliance in patients after coronary artery bypass graft surgery. Zhonghua Xin Xue Guan Bing Za Zhi 2011, 39(2):160-163.
39. Kim Y.S., Sunwoo S., Lee H.R., Lee K.M., Park Y.W., Shin H.C., et al. Determinants of non-compliance with lipid-lowering therapy in hyperlipidemic patients. Pharmacoepidemiol Drug Saf 2002, 11(7):593-600.
40. Fridley J., Adams G., Rao V., Patel A., Humphries W., Goodman C., et al. Small cell lung cancer metastasis in the pituitary gland presenting with seizures and headache. J Clin Neurosci 2011, 18(3):420-422.
41. Herrak L., Jahnaoui N., Hammi S., Ei Asri N., Achachi L., EI Ftouh M., et al. Cerebral metastasis of a "ghost" bronchopulmonary tumor. Rev Pneumol Clin 2012, 68(4):243-248.
42. Fadul C.E., Stommel E.W., Dragnev K.H., Eskey C.L., Dalmau J.O. Focal paraneoplastic limbic encephalitis presenting as orgasmic epilepsy. J Neurooncol 2005, 72(2):195-198.
43. Dardis C., Craciun R., Schell R. Posterior reversible encephalopathy syndrome in the setting of COPD: proposed pathogenesis. Med Hypotheses 2013, 80(2):197-200.
44. De-Giorgio F., Grassi V.M., Miscusi M., Mancuso C., d'Aloja E., Pascali V.L. Subarachnoid hemorrhage and carbon monoxide exposure: accidental association or fatal linkα. J Forensic Sci 2013, 58(5):1364-1366.
45. Singh K. Effect of smoking on QT interval, OT dispersion and rate pressure product. Indian Heart J 2004, 56(2):140-142.
46. Sethi N.K. Atrial fibrillation associated with epileptic seizures. JAMA Neurol 2013, 0(2):273-274.
47. Lin Y., Yagyu K., Ueda J., Kurosawa M., Tamakoshi A., Kikuchi S., et al. Active and passive smoking and risk of death from pancreatic cancer: findings from the Japan Collaborative Cohort Study. Pancreatology 2013, 13(3):279-284.
48. Theis R.P., Dolwick Grieb S.M., Burr D., Siddiqui T., Asal N.R. Smoking, environmental tobacco smoke, and risk of renal cell cancer: a population-based case-control study. BMC Cancer 2008, 8:387.
49. Di Cello F., Flowers V.L., Li H., Vecchio-Oagan B., Gordon B., Harbom K., et al. Cigarette smoke induces epithelial to mesenchymal transition and increases the metastatic ability of breast cancer cells. Mol Cancer 2013, 12:90. 10.1186/1476-4598-12-90.
50. Nagore E., Hueso L., Botella-Estrada R., Alfaro-Rubio A., Serna I., Guallar J., et al. Smoking, sun exposure, number of nevi and previous neoplasias are risk factors for melanoma in old patients (60years and over). J Eur Acad Dermatol Venereol 2010, 24(1):50-57.
51. Fu Z., Shrubsole M.J., Li G., Smalley W.E., Hein D.W., Cai Q., et al. Interaction of cigarette smoking and carcinogen-metabolizing polymorphisms in the risk of colorectal polyps. Carcinogenesis 2013, 34(4):779-786.
52. Lateef A., Rehman M.U., Tahir M., Khan R., Khan A.Q., Qamar W., et al. Farnesol protects against intratracheally instilled cigarette smoke extract-induced histological alterations and oxidative stress in prostate of Wistar rats. Toxicol Int 2013, 20(1):35-42.
53. Krassas G.E., Wiersinga W. Smoking and autoimmune thyroid disease: the plot thickens. Eur J Endocrinol 2006, 154(6):777-780.
54. Knudsen N., Bulow I., Laurberg P., Perrild H., Ovesen L., Jorgensen T. High occurrence of thyroid multinodularity and low occurrence of subclinical hypothyroidism among tobacco smokers in a large population study. J Endocrinol 2002, 175(3):571-576.
55. Gerber P.A., Locher R., Schmid B., Spinas G.A., Lehmann R. Smoking is associated with impaired long-term glucose metabolism in patients with type 1 diabetes mellitus. Nutr Metab Cardiovasc Dis 2013, 23(2):102-108.
56. Dulger H., Donder A., Sekeroglu M.R., Erkoc R., Ozbay B. Investigation of the relationship between serum levels of cotinine and the renal function in active and passive smokers. Ren Fail 2011, 33(5):475-479.
57. Vander Top E.A., Wyatt T.A., Gentry-Nielsen M.J. Smoke exposure exacerbates an ethanol-induced defect in mucociliary clearance of Streptococcus pneumonia. Alcohol Clin Exp Res 2005, 29(5):882-887.
58. Madruga C.S., Laranjeira R., Caetano R., Pinsky I., Zaleski M., Ferri C.P. Use of licit and illicit substances among adolescents in Brazil-a national survey. Addict Behav 2012, 37(10):1171-1175.
59. Kilty S.J., Gaboury I. Clinical predictors of peritonsillar abscess in adults. J Otolaryngol Head Neck Surg 2008, 37(2):165-168.
60. Luo X., Duan S., Duan Q., Pu Y., Yang Y., Ding Y., et al. Tobacco use among HIV infected individuals in a rural community in Yunna Province, China. Drug Alcohol Depend 2013, (pii: S0376-8716(13)00402-X), in press.
61. Rava M., Paul A. Cerebral venous thrombosis and venous infarction: case report of a rare initial presentation of smoker's polycythemia. Case Rep Neurol 2010, 2(3):150-156.
62. Thakur K.T., Westover M.B. Cerebral infarction due to smoker's polycythemia. BMJ Case Rep 2011, 10.1136/bcr.08.2011.4714.
63. Koh W.P., Robien K., Wang R., Govindarajan S., Yuan J.M., Yu M.C. Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese Health Study. Br J Cancer 2011, 105(9):1430-1435.
64. Shih W.L., Chang H.C., Liaw Y.F., Lin S.M., Lee S.D., Chen P.J., et al. Influences of tobacco and alcohol use on hepatocellular carcinoma survival. Int J Cancer 2012, 131(11):2612-2621.
65. Kasznia-Kocot J., Bulanowska Z. Passive smoking as the cause of life-threatening intoxication in a child. Wiad Lek 1992, 45(21-22):873-874.
66. Ischander M., Fan L.L., Farahmand V., Langston C., Yazdani S. Desquamative interstitial pneumonia in a child related to cigarette smoke. Pediatr Pulmonol 2013, 10.1002/ppul.22812.
67. Tal A., Maor E., Bar-Ziv J., Gorodischer R. Fatal desquamative interstitial pneumonia in three infants siblings. J Pediatr 1984, 104(6):873-876.
68. Asadi-Pooya A.A., Hojabri K. Risk factors for childhood epilepsy: a case control study. Epilepsy Behav 2005, 6(2):203-206.
69. Voigt M., Neudecker K., Schneider K.T., Olbertz D., Briese V., Straube W., et al. Effects of smoking specified as cigarettes per day and maternal body mass index on hypertensive disorder of pregnancy. Z Geburtshilfe Neonatol 2013, 217(1):24-27.
70. Wasay M., Kaul S., Menon B., Venketasubramanian N., Gunaratne P., Khalifa A., et al. Ischemic stroke in young Asian women: risk factors, subtypes and outcome. Cerebrovasc Dis 2010, 30(4):418-422.
71. Reinsberger C., Dorn T., Kramer G. Smoking reduces serum levels of lamotrigine. Seizure 2008, 17(7):651-653.
72. Chelchowska M., Ambroszkiewicz J., Jablonka-Salach K., Gaiewska J., Maciejewski T.M., Bulska E., et al. Tobacco smoke exposure during pregnancy increases maternal blood lead levels affecting neonate birth weight. Biol Trace Elem Res 2013, 155(2):169-175.
73. Keegan J., Parva M., Finnegan M., Gerson A., Belden M. Addiction in pregnancy. J Addict Dis 2010, 29(2):175-191. 10.1080/10550881003684723.
74. Rantakallio P., Koiranen M. Neurological handicaps among children whose mothers smoked during pregnancy. Prev Med 1987, 16(5):597-606.
75. Streja E., Miller J.E., Bech B.H., Greene N., Pedersen L.H., Yeargin-Alisonpp M., et al. Congenital cerebral palsy and prenatal exposure to self-reported maternal infections, fever, or smoking. Am J Obstet Gynecol Oct 2013, 209(4):332.e1-332.e10.
76. Harden C.L., Hopp J., Ting T.Y., Pennell P.B., French J.A., Hauser W.A., et al. Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the quality standards subcommittee and therapeutics and technology assessment subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009, 73(2):126-132.
77. Singhi P., Saini A.G. Changes in the clinical spectrum of cerebral palsy over two decades in North India-an analysis of 1212 cases. J Trop Pediatr 2013, 59:434-440.
78. Darmency-Stamboul V., Chantegret C., Ferdynus C., Mejean N., Durand C., Sagot P., et al. Antenatal factors associated with perinatal arterial ischemic stroke. Stroke 2012, 43(9):2307-2312.
79. Visser A.M., Jaddoe V.W., Hofman A., Moll H.A., Steegers E.A., Tiemeier H., et al. Fetal growth retardation and risk of febrile seizures. Pediatrics 2010, 126(4):e919-e925.
80. Sidenvall R., Heijbel J., Blomquist H.K., Nystrom L., Forsgren L. An incident case-control study of first unprovoked afebrile seizures in children: a population-based study of pre-and perinatal risk factors. Epilepsia 2001, 42(10):1261-1265.
81. Vahidnia F., Eskenazi B., Jewell N. Maternal smoking, alcohol drinking and febrile convulsion. Seizure 2008, 17(4):320-326.
82. Vestergaard M., Wisborg K., Henriksen T.B., Secher N.J., Ostergaard J.R., Olsen J. Prenatal exposure to cigarettes, alcohol, and coffee and the risk for febrile seizures. Pediatrics 2005, 116(5):1089-1094.
83. Berg A.T., Shinnar S., Shapiro E.D., Salomon M.E., Crain E.F., Hause W.A. Risk factors for a first febrile seizure: a matched case control study. Epilepsia 1995, 36(4):334-341.
84. Cassano P.A., Koepsell T.D., Farwell J.R. Risk of febrile seizures in childhood in relation to prenatal maternal cigarettes smoking and alcohol intake. Am J Epidemiol 1990, 132(3):462-473.
85. Nelson K.B., Ellenberg J.H. Prenatal and perinatal antecedents of febrile seizures. Ann Neurol 1990, 27(2):127-131.
86. Roza S.J., Verburg B.O., Jaddoe V.W., Hofman A., Mackenbach J.P., Steegers E.A., et al. Effects of maternal smoking in pregnancy on prenatal brain development: the Generation R Study. Eur J Neurosci 2007, 25(3):611-617.
87. Derauf C., Lester B.M., Neyzi N., Kekatpure M., Geracia L., Davis J., et al. Subcortical and cortical structural central nervous systemchanges and attention processing deficits in preschool-aged children with prenatal methamphetamine and tobacco exposure. Dev Neurosci 2012, 34(4):327-341.
88. Ekblad M., Korkeila J., Parkkola R., Lapinleimu H., Haataja L., Lehtonen L., Derauf C., et al. Maternal smoking during pregnancy and regional brain volumes in preterm infants. J Pediatr 2010, 156(2):185-190.
89. Falk L., Nordberg A., Seiger A., Kjaeldgaard A., Hellstrom-Lindahl E. Smoking during early pregnancy affects the expression pattern of both nicotinic and muscarinic acetylcholine receptors in human first trimester brainstem and cerebellum. Neuroscience 2005, 132(2):389-397.
90. Kedmi M., Orr-Irtreger A. Expression changes in mouse brains following nicotine-induced seizures: the modulation of transcription factor networks. Physiol Genomics 2007, 30(3):242-252.
91. Nashef L., So E.L., Ryvlin P., Tomson T. Unifying the definitions of sudden unexpected death in epilepsy. Epilepsia 2012, 53(2):227-233.
92. Rehan V.K., Asotra K., Torday J.S. The effects of smoking on the developing lung: insights from a biologic model for lung development, homeostasis, and repair. Lung 2009, 187(5):281-289.
93. Thomakos P., Liatis S., Kalopita S., Vlahodimitris I., Strathi C., Katsilambros N., et al. Cigarette smoking is associated with prolongation of the QTc interval duration in patients with type 2 diabetes mellitus. Int J Endocrinol 2013, 2013:329189.
94. D'Alessandro A., Boeckelmann I., Hammwhoner M., Goette A. Nicotine, cigarette smoking and cardiac arrhythmia: an overview. Eur J Prev Cardiol 2012, 19(3):297-305.
95. Ashare R.L., Sinha R., Lampert R., Weinberger A.H., Anderon G.M., Lavery M.E., et al. Blunted vagal reactivity predicts stress-precipitated tobacco smoking. Psychopharmacology (Berl) 2012, 220(2):259-269.
96. Stollberger C., Finsterer J. Cardiorespiratory findings in sudden unexplained/unexpected death in epilepsy (SUDEP). Epilepsy Res 2004, 59(1):51-60.
97. Kim H.C., Jhoo W.K., Ko K.H., Kim W.K., Bing G., Kwon M.S., et al. Prolonged exposure to cigarette smoke blocks the neurotoxicity induced by kainic acid in rats. Life Sci 2000, 66(4):317-326.
98. Beleslin D.B., Krstic S.K. Nicotine-induced convulsions in cats and central nicotinic receptors. Pharmacol Biochem Behav 1986, 24(6):1509-1511.
99. Damaj M.I., Glassco W., Dukat M., Martin B.R. Pharmacological characterization of nicotine-induced seizures in mice. J Pharmacol Exp Ther 1999, 291(3):1284-1291.
100. Sood N., Sahai A.K., Medhi B., Chakrabarti A. Dose-finding study with nicotine as a proconvulsant agent in PTZ-induced seizure model in mice. J Biomed Sci 2008, 15(6):755-765.
101. Sood N., Hota D., Sahai A.K., Chakrabarti A. Nicotine reversal of anticonvulsant action of topiramate in kainic acid induced seizure model in mice. Nicotine Tob Res 2011, 13(11):1084-1091.
102. Tuncok Y., Hieda Y., Keyler D.E., Brown S., Ennifar S., Fattom A., et al. Inhibition of nicotine-induced seizures in rats by combining vaccination against nicotine with chronic nicotine infusion. Exp Clin Psychopharmacol 2001, 9(2):228-234.
103. Turski W.A., Cavalheiro E.A., Schwarz M., Czuczwar S.J., Kleinrok Z., Turski L. Limbic seizures produced by pilocarpine in rats: behavioral, electroencephalographic and neuropathological study. Behav Brain Res 1983, 9(3):315-335.
104. de Fiebre C.M., Collins A.C. Decreased sensitivity to nicotine-induced seizures as a consequence of nicotine pretreatment in long-sleep and short-sleep mice. Alcohol 1988, 5(1):55-61.
105. Uzum G., Diler A.S., Ziylan Z. Chronic nicotine pretreatment protects the blood brain barrier against nicotine-induced seizures in the rat. Pharmacol Res 1999, 40(3):263-269.
106. Gomes P.X., de Oliveira G.V., de Araujo F.Y., de Barros Viana G.S., de Sousa F.C., Hyogantis T.N., et al. Differences in vulnerability to nicotine-induced kindling between female and male periadolescent rats. Psychopharmacology (Berl) 2013, 225(1):115-126.
107. Czuczwar M., Kis J., Czuczwar P., Wielosz M., Turski W. Nicotine diminishes anticonvulsant activity of antiepileptic drugs in mice. Pol J Pharmacol 2003, 55(5):799-802.
108. Stead L.F., Lancaster T. Behavioral interventions as adjuncts to pharmacotherapy for smoking cessation. Cochrane Database Syst Rev 2012, 12:CD009670.
109. Cahill K., Stevens S., Perera R., Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev 2013, 5:CD009329.
110. Prochaska J.J., Das S., Benowitz N.L. Cytisine, the world's oldest smoking cessation aid. BMJ 2013, 347:f5198. 10.1136/bmj.f5198.
111. Glassman A.H., Jackson W.K., Walsh B.T., Roose S.P., Rosenfeld B. Cigarette craving, smoking withdrawal, and clonidine. Science 1984, 226:864-866.
112. Polosa R., Rodu B., Caponnetto P., Maglia M., Raciti C. A fresh look at tobacco harm reduction: the case of the electronic cigarette. Harm Reduct J 2013, 10(1):19.
113. Boora K., Cummings M.R., Marshall D.R. Generalized seizures in three adolescents with bupropion overdose. J Child Adolesc Psychopharmacol 2010, 20(2):159-160.
114. Dersch R., Zwernemann S., Voderholzer U. Partial status epilepticus after electroconvulsive therapy and medical treatment with bupropion. Pharmacopsychiatry 2011, 44(7):344-346.
115. Serafini A., Crespel A., Velizara R., Gelisse P. Varenicline-induced grand mal seizure. Epileptic Disord 2010, 12(4):338.
116. Feron F.J., Hendriksen J.G., Nicolai J., Vles J.S. New-onset seizures: a possible association with clonidine. Pediatr Neurol 2008, 38(2):147-149.
117. Schmitt H., Druschky K., Hummel C., Stefan H. Detection of an epileptic mirror focus after oral application of clonidine. Br J Anaesth 1999, 83(2):349-351.
118. Lipper B., Bell A., Gaynor B. Recurrent hypotension immediately after seizures in nortriptyline overdose. Am J Emerg Med 1994, 12(4):452-453.
119. Grover C.A., Flaherty B., Lung D., Pageler N.M. Significant toxicity in a young female after low dose tricyclic antidepressant ingestion. Pediatr Emerg Care 2012, 28(10):1066-1069.
120. Tutka P., Mroz T., Bednarski J., Styk A., Ognik J., Mosiewicz J., et al. Cytisine inhibits the anticonvulsant activity of phenytoin and lamotrigine in mice. Pharmacol Rep 2013, 65(1):195-200.
121. Morazin F., Lumbroso A., Harry P., Blaise M., Turcant A., Montravers P., et al. Cardiogenic shock and status epilepticus after massive bupropion overdose. Clin Toxicol (Phila) 2007, 45(7):794-797.
122. Starr P., Klein-Schwartz W., Spiller H., Kern P., Ekleberry S.E., Kunkel S. Incidence and onset of delayed seizures after overdoses of extended-release bupropion. Am J Emerg Med 2009, 27(8):911-915.
123. Spiller H.A., Scheffer S.E. Multiple seizures after bupropion overdose in a small child. Pediatr Emerg Care 2008, 24(7):474-475.
124. Rissmiller D.J., Campo T. Extended-release bupropion induced grand mal seizures. J Am Osteopath Assoc 2007, 107(10):441-442.
125. Tutka P., Mroz T., Klucha K., Piekarczyk M., Wielosz M. Bupropion-induced convulsions: preclinical evaluation of antiepileptic drugs. Epilepsy Res 2005, 64(1-2):13-22.
126. Tutka P., Barczynski B., Wielosz M. Convulsant and anticonvulsant effects of bupropion in mice. Eur J Pharmacol 2004, 499(1-2):117-120.
127. Barczynski B., Buszewicz G., Luszczki J.J., Banka K., Tutaj K., Mroz T., et al. Low dose of bupropion significantly enhances the anticonvulsant activity of felbamate, lamotrigine and topiramate in mice. Eur J Pharmacol 2011, 650(2-3):550-555.
128. Lin K.C., Wang C.C., Wang S.J. Bupropion attenuates kainic acid-induced seizures and neuronal cell death in rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 2013, 45:207-214.
129. Loscher W., Czuczwar S.J. Comparison of drugs with different selectivity for central alpha 1 and alpha 2 adrenoceptors in animal models of epilepsy. Epilepsy Res 1987, 1(3):165-172.
130. Babington R.G., Wedeking P.W. The pharmacology of seizures induced by sensitization with low intensity brain stimulation. Pharmacol Biochem Behav 1973, 1(4):461-467.
131. Tamboli A.M., Rub R.A., Ghosh P., Bodhankar L. Antiepileptic activity of lobeline isolated from the leaf of Lobelia nicotianaefolia and its effect on brain GABA level in mice. Asian Pac J Trop Biomed 2012, 2(7):537-542.